These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11519049)

  • 1. Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging.
    Moehler TM; Hawighorst H; Neben K; Egerer G; Hillengass J; Max R; Benner A; Ho AD; van Kaick G; Goldschmidt H
    Int J Cancer; 2001 Sep; 93(6):862-8. PubMed ID: 11519049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional magnetic resonance tomography in the diagnosis and therapy monitoring in multiple myeloma].
    Moehler TM; Hawighorst H; Neben K; Egerer G; Benner A; Hillengass J; Max R; Ho AD; Goldschmidt H; van Kaick G
    Radiologe; 2000 Aug; 40(8):723-30. PubMed ID: 11006943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma.
    Hillengass J; Wasser K; Delorme S; Kiessling F; Zechmann C; Benner A; Kauczor HU; Ho AD; Goldschmidt H; Moehler TM
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):475-81. PubMed ID: 17255268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma.
    Hillengass J; Ritsch J; Merz M; Wagner B; Kunz C; Hielscher T; Laue H; Bäuerle T; Zechmann CM; Ho AD; Schlemmer HP; Goldschmidt H; Moehler TM; Delorme S
    Br J Haematol; 2016 Jul; 174(1):127-35. PubMed ID: 26991959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracranial meningeomas: time- and dose-dependent effects of irradiation on tumor microcirculation monitored by dynamic MR imaging.
    Hawighorst H; Engenhart R; Knopp MV; Brix G; Grandy M; Essig M; Miltner P; Zuna I; Fuss M; van Kaick G
    Magn Reson Imaging; 1997; 15(4):423-32. PubMed ID: 9223043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamic contrast-enhanced MRI for evaluating bone marrow microcirculation in malignant hematological diseases before and after thalidomide therapy].
    Scherer A; Strupp C; Wittsack HJ; Engelbrecht V; Willers R; Germing U; Gattermann N; Haas R; Mödder U
    Radiologe; 2002 Mar; 42(3):222-30. PubMed ID: 11963240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dynamic MRI of the bone marrow for monitoring multiple myeloma during treatment with thalidomide as monotherapy or in combination with CED chemotherapy].
    Wasser K; Moehler T; Neben K; Nosas S; Heiss J; Goldschmidt H; Hillengass J; Düber C; Kauczor HU; Delorme S
    Rofo; 2004 Sep; 176(9):1285-95. PubMed ID: 15346264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study.
    Merz M; Moehler TM; Ritsch J; Bäuerle T; Zechmann CM; Wagner B; Jauch A; Hose D; Kunz C; Hielscher T; Laue H; Goldschmidt H; Delorme S; Hillengass J
    Eur Radiol; 2016 May; 26(5):1404-11. PubMed ID: 26215436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation.
    Hillengass J; Zechmann C; Bäuerle T; Wagner-Gund B; Heiss C; Benner A; Ho A; Neben K; Hose D; Kauczor HU; Goldschmidt H; Delorme S; Moehler T
    Clin Cancer Res; 2009 May; 15(9):3118-25. PubMed ID: 19366830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.
    Stäbler A; Baur A; Bartl R; Munker R; Lamerz R; Reiser MF
    AJR Am J Roentgenol; 1996 Oct; 167(4):1029-36. PubMed ID: 8819407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parametric histogram analysis of dynamic contrast-enhanced MRI in multiple myeloma: a technique to evaluate angiogenic response to therapy?
    Zechmann CM; Traine L; Meissner T; Wagner-Gund B; Giesel FL; Goldschmidt H; Delorme S; Hillengass J
    Acad Radiol; 2012 Jan; 19(1):100-8. PubMed ID: 22142682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced MRI in Paget's disease of bone--correlation of regional microcirculation and bone turnover.
    Libicher M; Kasperk C; Daniels M; Hosch W; Kauczor HU; Delorme S
    Eur Radiol; 2008 May; 18(5):1005-11. PubMed ID: 18175121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: a comparative study with histology and clinical markers.
    Nosàs-Garcia S; Moehler T; Wasser K; Kiessling F; Bartl R; Zuna I; Hillengass J; Goldschmidt H; Kauczor HU; Delorme S
    J Magn Reson Imaging; 2005 Jul; 22(1):154-62. PubMed ID: 15971177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission.
    Chen BB; Hsu CY; Yu CW; Hou HA; Liu CY; Wei SY; Chou WC; Tien HF; Shih TT
    Radiology; 2011 Mar; 258(3):821-31. PubMed ID: 21212370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced magnetic resonance imaging for assessment of antiangiogenic treatment effects in multiple myeloma.
    Merz M; Ritsch J; Kunz C; Wagner B; Sauer S; Hose D; Moehler T; Delorme S; Goldschmidt H; Zechmann C; Hillengass J
    Clin Cancer Res; 2015 Jan; 21(1):106-12. PubMed ID: 25351744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients.
    Moulopoulos LA; Dimopoulos MA; Kastritis E; Christoulas D; Gkotzamanidou M; Roussou M; Koureas A; Migkou M; Gavriatopoulou M; Eleutherakis-Papaiakovou E; Gika D; Koutoulidis V; Terpos E
    Am J Hematol; 2012 Sep; 87(9):861-4. PubMed ID: 22641455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neovascularization of bone marrow in patients with diffuse multiple myeloma: a correlative study of magnetic resonance imaging and histopathologic findings.
    Baur A; Bartl R; Pellengahr C; Baltin V; Reiser M
    Cancer; 2004 Dec; 101(11):2599-604. PubMed ID: 15503306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does dynamic contrast-enhanced MRI enable recognition of development of vertebral fractures in multiple myeloma?].
    Scherer A; Wittsack HJ; Engelbrecht V; Strupp C; Poll LW; Willers R; Schneider P; Gattermann N; Haas R; Mödder U
    Rofo; 2002 Aug; 174(8):984-90. PubMed ID: 12142975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
    Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
    AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.